SBI Healthcare Opportunities Fund - Growth - Regular Plan

Other Plans and Options
  • 1.06 %Nav, as on 04-08-2020

  • Previous Nav

  • Net Change on 04-08-2020

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Regular Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

To provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
SBI HEALTHCARE OPPORTUNITIES FUND - REGULAR PLAN -GROWTH 12.75 17.37 52.53 9.12 2.89 15.08
S&P BSE Health Care 13.99 21.25 48.38 10.30 1.71 14.56
S&P BSE Health Care - TRI 14.18 21.49 49.74 11.11 2.37 14.07
S&P BSE SENSEX - TRI 5.00 19.51 2.64 6.49 7.40 12.52

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
SBI HEALTHCARE OPPORTUNITIES FUND - REGULAR PLAN -GROWTH Jul 14, 1999 52.53 9.12 2.89 2.43 1,154.42
Nippon India Pharma Fund-Growth Plan-Growth Jun 05, 2004 54.44 18.26 8.45 2.07 3,092.66
UTI Healthcare Fund - Regular Plan - Growth Option Aug 01, 2005 53.84 12.25 4.40 2.81 480.89

Fund Holdings as on 30-June-2020

  • Sun Pharmaceutical Industries Ltd.

  • Cipla Ltd.

  • Aurobindo Pharma Ltd.

  • Lupin Ltd.

  • Dr. Reddy's Laboratories Ltd.

  • Divi's Laboratories Ltd.

  • Alembic Pharmaceuticals Ltd.

  • Abbott India Ltd.

  • Biocon Ltd.

  • Strides Pharma Science Ltd.

  • Narayana Hrudayalaya Ltd.

  • Ajanta Pharma Ltd.

  • Natco Pharma Ltd.

  • Apollo Hospitals Enterprise Ltd.

  • Gufic Biosciences Ltd.

  • Sequent Scientific Ltd.

  • TREPS

  • Pfizer Ltd.

  • Sanofi India Ltd.

  • Glaxosmithkline Pharmaceuticals Ltd.

  • Solara Active Pharma Sciences Ltd.

  • Thyrocare Technologies Ltd.

  • Aster DM Healthcare Ltd.

  • Metropolis Healthcare Ltd.

  • Shreno Ltd.

  • Margin amount for Derivative positions

  • Net Receivable / Payable

View More

  • Pharmaceuticals & Drugs

  • Hospital & Healthcare Services

  • Miscellaneous

  • Diversified

View More

Fund Manager

  • Education:B.E (Electronics),MBA (Finance),C.F.A(USA) Level III candidate
  • Experience:6 years
  • Basic Details:Mr. Desai has close to 6 years of work experience with over 3 years of experience in Indian capital markets. He has been associated with SBI Funds Management Private Limited from May 2008. Prior to join SBI Funds Management Pvt. Ltd. he was a lecturer in Electronics Department with D J Sanghvi College of Engineering, Mumbai.
  • Funds Managed:
  • SBI Healthcare Opportunities Fund

  • Cash

  • Equity

  • Preference Shares

View More

About SBI Healthcare Opportunities Fund

Scheme Analysis

SBI Healthcare Opportunities Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to SBI Mutual Fund. It was launched on 14-Jul-1999 and currently has an AUM of ₹1,154.42 crore. SBI Healthcare Opportunities Fund is benchmarked against S&P BSE Health Care as primary index and S&P BSE Health Care - TRI as primary index and S&P BSE SENSEX - TRI as secondary index.

The NAV of SBI Healthcare Opportunities Fund ended up ₹1.73(1.06%)yesterday to ₹165.368.

Among its top 3 holdings the fund has exposure to Sun Pharmaceutical Industries Ltd., and

The SBI Healthcare Opportunities Fund is managed by Tanmaya Desai .

Fund House Contact

191, Maker Tower 'E' Cuffe Parade Mumbai - 400 005

022 - 22180221-27
022 - 22189663
www.sbimf.com